Abstract
1534P Multivariable analysis of real-world clinical outcomes associated with dose reductions (DRs) for patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have